SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-21-012171
Filing Date
2021-02-26
Accepted
2021-02-26 16:49:39
Documents
1
Period of Report
2021-02-24

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 11304
  Complete submission text file 0001213900-21-012171.txt   12700
Mailing Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022 646 876 3459
RELMADA THERAPEUTICS, INC. (Issuer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 EAST 56TH STREET, APT 19E NEW YORK, NY 10022
Business Address
Kelly Paul Edward (Reporting) CIK: 0001658544 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39082 | Film No.: 21690228